We announce the commercial launch of the Thermo Scientific B·R·A·H·M·S Inhibin A KRYPTOR test on January 28, 2019. The B·R·A·H·M·S Inhibin A KRYPTOR test is indicated as an aid to be used in conjunction with the clinical evaluation for non-invasive risk assessment of fetal trisomy 21 in the second trimester in pregnant women. With the launch of Inhibin A KRYPTOR Thermo Fisher Scientific can now offer all prenatal screening biomarkers assays on the B·R·A·H·M·S KRYPTOR GOLD autoimmunoanalyser to customers in CE mark accepting countries.


Further links on prenatal screening products and assays

thermo scientific applied biosystems invitrogen fisher scientific unity lab service